Fulgent Genetics, Inc. (FLGT) Tops Q1 EPS by 73c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Fulgent Genetics Reports Record First Quarter Financial Results
May 6, 2021 4:05 PM EDTFirst Quarter 2021 Results:
Record Revenue of $359.4 million, growing more than 4,500% year-over-year Record Billable tests delivered approximately 3.8 million, or 290 times the volume of first quarter of 2020 Gross Margin improved approximately 32 percentage points year-over-year NGS Revenue grew 115% year-over-year Record GAAP income of $200.7 million, or $6.52 per share Record Non-GAAP income of $202.9 million, or $6.59 per share Record Adjusted EBITDA of $271.9 million Cash from operations of $233.2 million; Cash and investments of $697.4 million as of March 31, 20212021 Outlook:
Raises full year total revenue outlook to $830 million from $800 million,... More